Amalgamated Financial’s Globus Medical GMED Stock Holding History

Amalgamated Financial’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$4.14M	Buy	+56,079	New	+$3.9M	0.03%	563

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Amalgamated Financial's GMED Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Globus Medical (GMED) in Q1 2022: 56,079 shares worth $4.14M. The stake represents 0.03% of the portfolio and ranks #563 among its holdings.

377 funds tracked by Wall St. Rank hold GMED as of Q1 2022.

Amalgamated Financial held 56,079 shares of Globus Medical worth $4.14M as of Q1 2022.
Globus Medical was a new Amalgamated Financial position in Q1 2022.
Globus Medical made up 0.03% of Amalgamated Financial's portfolio in Q1 2022, its #563 holding.
377 funds tracked by Wall St. Rank held Globus Medical as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.